Yahoo Web Search

  1. Ad
    related to MERCK & CO., INC
  1. Merck (MRK) Stock Moves -1.33%: What You Should Know

    Zacks via Yahoo FinanceOct 08 21:45 PM

    Prior to today's trading, shares of the pharmaceutical company had gained 1.1% over the past month. This has outpaced the Medical sector's loss of 3.6% and the S&P 500's loss of 1.22% in that ...

  2. U.S. stocks rose on Monday, helped by surges in Apple and Merck & Co as investors set aside worries about the U.S.-China trade war. Shares of Apple rose 2.4% after Chief Executive ...

  3. AstraZeneca Plc and Merck & Co Inc said on Monday their treatment for newly diagnosed advanced ovarian cancer improved progression-free survival in patients tested in a ...

  4. AstraZeneca plc AZN presented detailed data from a phase III study evaluating the company’s and Merck’s MRK PARP inhibitor, Lynparza, as a precision medicine for an advanced prostate ...

  5. The study tested Lynparza in patients as an add-on to an already existing standard of care, bevacizumab, and was compared to a group of patients given bevacizumab alone. The treatment showed ...

  6. AstraZeneca Plc and Merck & Co Inc said on Monday their drug to treat a form of ovarian cancer improved progression-free survival in patients tested in a late-stage study ...

  7. Seattle Genetics Up More Than 20% in 3 Months: Here's Why

    Zacks via Yahoo FinanceOct 10 15:15 PM

    Shares of Seattle Genetics, Inc. SGEN have rallied 22.7% against the industry's decline of 9.6%. The company's sole marketed drug, Adcetris, is approved for relapsed Hodgkin lymphoma ...

  8. Descovy for PrEP is indicated to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg, who are HIV-negative and at-risk for sexually acquired ...

  9. Verastem's (VSTM) Copiktra Gets Orphan Drug Designation

    Zacks via Yahoo FinanceOct 08 14:02 PM

    Verastem, Inc. VSTM announced that the FDA has granted orphan drug designation to Copiktra (duvelisib) for the treatment of T-Cell lymphoma. The drug already enjoys Fast Track designation for this indication.

  10. Attention from political leaders is not lost on Kenneth Frazier, the chief executive of top pharmaceutical company Merck (MRK), who said on Thursday that the pharmaceutical industry “ ...

  1. Ad
    related to MERCK & CO., INC